Title: ADHD Medications: Risk, Bias, and Real Outcomes Hosts: James Kennedy, PMHNP-BC & Jon Murphy, PMHNP-BC
In this first episode of Compass Point Institute, James and Jon break down a major new study published in JAMA Psychiatry (June 25, 2025) tracking ADHD medication outcomes in over 260,000 individuals.
🎯 Topics covered:
Key findings from a 15-year longitudinal study
Reduced self-harm, accident, and criminal risk
Navigating stigma, DEA scrutiny, and Schedule II status
Provider bias and the myth of “weekend breaks”
Practical clinical guidance on stimulant prescribing
The difference between physiological vs psychological addiction
This episode is designed to support mental health clinicians with real-world data, clear context, and grounded insight.
📬 Have a topic you want us to cover? Reach out anytime. 🧭 Compass Point Institute — Empowering the next generation of mental health clinicians.
